137 related articles for article (PubMed ID: 17334509)
1. Platelet activation via PAR4 is involved in the initiation of thrombin generation and in clot elasticity development.
Vretenbrant K; Ramström S; Bjerke M; Lindahl TL
Thromb Haemost; 2007 Mar; 97(3):417-24. PubMed ID: 17334509
[TBL] [Abstract][Full Text] [Related]
2. PAR4, but not PAR1, signals human platelet aggregation via Ca2+ mobilization and synergistic P2Y12 receptor activation.
Holinstat M; Voss B; Bilodeau ML; McLaughlin JN; Cleator J; Hamm HE
J Biol Chem; 2006 Sep; 281(36):26665-74. PubMed ID: 16837456
[TBL] [Abstract][Full Text] [Related]
3. A mouse model of the protease-activated receptor 4 Pro310Leu variant has reduced platelet reactivity.
Han X; Knauss EA; Fuente M; Li W; Conlon RA; LePage DF; Jiang W; Renna SA; McKenzie SE; Nieman MT
J Thromb Haemost; 2024 Jun; 22(6):1715-1726. PubMed ID: 38508397
[TBL] [Abstract][Full Text] [Related]
4. Suboptimal activation of protease-activated receptors enhances alpha2beta1 integrin-mediated platelet adhesion to collagen.
Marjoram RJ; Voss B; Pan Y; Dickeson SK; Zutter MM; Hamm HE; Santoro SA
J Biol Chem; 2009 Dec; 284(50):34640-7. PubMed ID: 19815553
[TBL] [Abstract][Full Text] [Related]
5. Proteinase-activated receptors 1 and 4 counter-regulate endostatin and VEGF release from human platelets.
Ma L; Perini R; McKnight W; Dicay M; Klein A; Hollenberg MD; Wallace JL
Proc Natl Acad Sci U S A; 2005 Jan; 102(1):216-20. PubMed ID: 15615851
[TBL] [Abstract][Full Text] [Related]
6. Common variants in the human platelet PAR4 thrombin receptor alter platelet function and differ by race.
Edelstein LC; Simon LM; Lindsay CR; Kong X; Teruel-Montoya R; Tourdot BE; Chen ES; Ma L; Coughlin S; Nieman M; Holinstat M; Shaw CA; Bray PF
Blood; 2014 Nov; 124(23):3450-8. PubMed ID: 25293779
[TBL] [Abstract][Full Text] [Related]
7. Molecular basis for activation and biased signaling at the thrombin-activated GPCR proteinase activated receptor-4 (PAR4).
Thibeault PE; LeSarge JC; Arends D; Fernandes M; Chidiac P; Stathopulos PB; Luyt LG; Ramachandran R
J Biol Chem; 2020 Feb; 295(8):2520-2540. PubMed ID: 31892516
[TBL] [Abstract][Full Text] [Related]
8. Protease-activated receptors and glycoprotein VI cooperatively drive the platelet component in thromboelastography.
Rudran T; Antoniak S; Flick MJ; Ginsberg MH; Wolberg AS; Bergmeier W; Lee RH
J Thromb Haemost; 2023 Aug; 21(8):2236-2247. PubMed ID: 37068592
[TBL] [Abstract][Full Text] [Related]
9. Complement factor C4a does not activate protease-activated receptor 1 (PAR1) or PAR4 on human platelets.
Han X; de la Fuente M; Nieman MT
Res Pract Thromb Haemost; 2021 Jan; 5(1):104-110. PubMed ID: 33537534
[TBL] [Abstract][Full Text] [Related]
10. Activation of protease-activated receptor (PAR) 1 by frog trefoil factor (TFF) 2 and PAR4 by human TFF2.
Zhang Y; Yu G; Wang Y; Xiang Y; Gao Q; Jiang P; Zhang J; Lee W; Zhang Y
Cell Mol Life Sci; 2011 Nov; 68(22):3771-80. PubMed ID: 21461878
[TBL] [Abstract][Full Text] [Related]
11. Irreversible platelet activation requires protease-activated receptor 1-mediated signaling to phosphatidylinositol phosphates.
Holinstat M; Preininger AM; Milne SB; Hudson WJ; Brown HA; Hamm HE
Mol Pharmacol; 2009 Aug; 76(2):301-13. PubMed ID: 19483102
[TBL] [Abstract][Full Text] [Related]
12. Discovery of Potent and Selective Quinoxaline-Based Protease-Activated Receptor 4 (PAR4) Antagonists for the Prevention of Arterial Thrombosis.
Zhang X; Jiang W; Richter JM; Bates JA; Reznik SK; Stachura S; Rampulla R; Doddalingappa D; Ulaganathan S; Hua J; Bostwick JS; Sum C; Posy S; Malmstrom S; Dickey J; Harden D; Lawrence RM; Guarino VR; Schumacher WA; Wong P; Yang J; Gordon DA; Wexler RR; Priestley ES
J Med Chem; 2024 Mar; 67(5):3571-3589. PubMed ID: 38385264
[TBL] [Abstract][Full Text] [Related]
13. Neutrophil cathepsin G proteolysis of protease-activated receptor 4 generates a novel, functional tethered ligand.
Stoller ML; Basak I; Denorme F; Rowley JW; Alsobrooks J; Parsawar K; Nieman MT; Yost CC; Hamilton JR; Bray PF; Campbell RA
Blood Adv; 2022 Apr; 6(7):2303-2308. PubMed ID: 34883511
[TBL] [Abstract][Full Text] [Related]
14. Identification of the minimum PAR4 inhibitor pharmacophore and optimization of a series of 2-methoxy-6-arylimidazo[2,1-b][1,3,4]thiadiazoles.
Temple KJ; Duvernay MT; Maeng JG; Blobaum AL; Stauffer SR; Hamm HE; Lindsley CW
Bioorg Med Chem Lett; 2016 Nov; 26(22):5481-5486. PubMed ID: 27777004
[TBL] [Abstract][Full Text] [Related]
15. Protease-Activated Receptor 4 (PAR4): A Promising Target for Antiplatelet Therapy.
Rwibasira Rudinga G; Khan GJ; Kong Y
Int J Mol Sci; 2018 Feb; 19(2):. PubMed ID: 29443899
[TBL] [Abstract][Full Text] [Related]
16. Discovery of 7, 4'-dimethoxy-3-hydroxyflavone as a protease-activated receptor 4 antagonist with antithrombotic activity and less bleeding tendency in mice.
Lin YT; Li Y; Hsu HC; Tsai JY; Lee JH; Tai CJ; Wu MJ; Wu CC
Biochem Pharmacol; 2022 Aug; 202():115152. PubMed ID: 35752281
[TBL] [Abstract][Full Text] [Related]
17. Use of Thrombodynamics for revealing the participation of platelet, erythrocyte, endothelial, and monocyte microparticles in coagulation activation and propagation.
Lipets EN; Antonova OA; Shustova ON; Losenkova KV; Mazurov AV; Ataullakhanov FI
PLoS One; 2020; 15(5):e0227932. PubMed ID: 32469873
[TBL] [Abstract][Full Text] [Related]
18. A Mouse Model of the Protease Activated Receptor 4 (PAR4) Pro310Leu Variant has Reduced Platelet Reactivity.
Han X; Knauss EA; de la Fuente M; Li W; Conlon RA; LePage DF; Jiang W; Renna SA; McKenzie SE; Nieman MT
bioRxiv; 2023 Dec; ():. PubMed ID: 38077081
[TBL] [Abstract][Full Text] [Related]
19. Platelet hyperactivity and fibrin clot structure in transient ischemic attack individuals in the presence of metabolic syndrome: a microscopy and thromboelastography study.
van Rooy MJ; Duim W; Ehlers R; Buys AV; Pretorius E
Cardiovasc Diabetol; 2015 Jul; 14():86. PubMed ID: 26140921
[TBL] [Abstract][Full Text] [Related]
20. Discovery of 2,3-Dihydro[1,4]dioxino[2,3-
Chen P; Chen C; Zheng Y; Chen F; Liu Z; Ren S; Song H; Liu T; Lu Z; Sun H; Kong Y; Yuan H
J Med Chem; 2024 Apr; 67(7):5502-5537. PubMed ID: 38552183
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
